{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:22Z","timestamp":1790838562224,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI148963"],"award-info":[{"award-number":["R01AI148963"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI127372"],"award-info":[{"award-number":["R01AI127372"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI151029"],"award-info":[{"award-number":["R01AI151029"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10875-023-01635-z","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T09:02:29Z","timestamp":1703840549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["IL4R\u03b1 and IL17A Blockade Rescue Autoinflammation in SOCS1 Haploinsufficiency"],"prefix":"10.1007","volume":"44","author":[{"given":"Conor","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofija","family":"Buta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saakshi","family":"Khattri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-en","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-3232","authenticated-orcid":false,"given":"Dusan","family":"Bogunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"issue":"7","key":"1635_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473\u2013507.","journal-title":"J Clin Immunol."},{"issue":"21","key":"1635_CR2","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857\u201376.","journal-title":"Cell."},{"issue":"7","key":"1635_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20151529","volume":"213","author":"ME Meuwissen","year":"2016","unstructured":"Meuwissen ME, et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J Exp Med. 2016;213(7):1163\u201374.","journal-title":"J Exp Med."},{"key":"1635_CR4","doi-asserted-by":"crossref","unstructured":"Gruber C, et al. Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy. J Exp Med. 2020;217(5)","DOI":"10.1084\/jem.20192319"},{"issue":"7532","key":"1635_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang X, et al. Human intracellular ISG15 prevents interferon-alpha\/beta over-amplification and auto-inflammation. Nature. 2015;517(7532):89\u201393.","journal-title":"Nature."},{"key":"1635_CR6","doi-asserted-by":"crossref","unstructured":"Duncan CJA, et al. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Sci Immunol. 2019;4(42)","DOI":"10.1126\/sciimmunol.aav7501"},{"issue":"7","key":"1635_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med."},{"issue":"1","key":"1635_CR8","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","volume":"11","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020;11(1):5341.","journal-title":"Nat Commun."},{"issue":"7814","key":"1635_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","volume":"583","author":"JED Thaventhiran","year":"2020","unstructured":"Thaventhiran JED, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020;583(7814):90\u20135.","journal-title":"Nature."},{"issue":"1","key":"1635_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","volume":"9","author":"NPD Liau","year":"2018","unstructured":"Liau NPD, et al. The molecular basis of JAK\/STAT inhibition by SOCS1. Nat Commun. 2018;9(1):1558.","journal-title":"Nat Commun."},{"key":"1635_CR11","doi-asserted-by":"publisher","first-page":"680334","DOI":"10.3389\/fimmu.2021.680334","volume":"12","author":"J Korholz","year":"2021","unstructured":"Korholz J, et al. One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency. Front Immunol. 2021;12:680334.","journal-title":"Front Immunol."},{"issue":"5","key":"1635_CR12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146(5):1194\u20131200 e1.","journal-title":"J Allergy Clin Immunol."},{"issue":"8","key":"1635_CR13","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s10875-022-01346-x","volume":"42","author":"TF Michniacki","year":"2022","unstructured":"Michniacki TF, et al. SOCS1 Haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition. J Clin Immunol. 2022;42(8):1766\u201377.","journal-title":"J Clin Immunol."},{"issue":"5","key":"1635_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10875-023-01460-4","volume":"43","author":"RC Hale","year":"2023","unstructured":"Hale RC, et al. Phenotypic variability of SOCS1 haploinsufficiency. J Clin Immunol. 2023;43(5):902\u20136.","journal-title":"J Clin Immunol."},{"issue":"5","key":"1635_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90(5):784\u201395.","journal-title":"Am J Hum Genet."},{"issue":"16","key":"1635_CR16","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"1635_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","volume":"53","author":"CN Gruber","year":"2020","unstructured":"Gruber CN, et al. Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function. Immunity. 2020;53(3):672\u2013684 e11.","journal-title":"Immunity."},{"issue":"5","key":"1635_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","volume":"98","author":"WS Alexander","year":"1999","unstructured":"Alexander WS, et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 1999;98(5):597\u2013608.","journal-title":"Cell."},{"issue":"5","key":"1635_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s13555-023-00918-y","volume":"13","author":"J Celakovska","year":"2023","unstructured":"Celakovska J, et al. Evaluation of leukocytes, B and T lymphocytes, and expression of CD200 and CD23 on B lymphocytes in patients with atopic dermatitis on dupilumab therapy-pilot study. Dermatol Ther (Heidelb). 2023;13(5):1171\u201392.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"10","key":"1635_CR20","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, et al. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2022;10(10):2695\u2013709.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"1635_CR21","doi-asserted-by":"publisher","first-page":"738316","DOI":"10.3389\/fphar.2021.738316","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, et al. Dynamics of adaptive immune cell and NK cell subsets in patients with ankylosing spondylitis after IL-17A inhibition by secukinumab. Front Pharmacol. 2021;12:738316.","journal-title":"Front Pharmacol."},{"issue":"7","key":"1635_CR22","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.4049\/jimmunol.162.7.3770","volume":"162","author":"JA Losman","year":"1999","unstructured":"Losman JA, et al. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol. 1999;162(7):3770\u20134.","journal-title":"J Immunol."},{"issue":"11","key":"1635_CR23","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.4049\/jimmunol.171.11.5901","volume":"171","author":"D Hebenstreit","year":"2003","unstructured":"Hebenstreit D, et al. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol. 2003;171(11):5901\u20137.","journal-title":"J Immunol."},{"issue":"6","key":"1635_CR24","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","volume":"139","author":"KL Del Bel","year":"2017","unstructured":"Del Bel KL, et al. JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. J Allergy Clin Immunol. 2017;139(6):2016\u20132020 e5.","journal-title":"J Allergy Clin Immunol."},{"key":"1635_CR25","doi-asserted-by":"crossref","unstructured":"Sharma M, et al. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. J Exp Med. 2023;220(5)","DOI":"10.1016\/j.clim.2023.109364"},{"issue":"2","key":"1635_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/sj.gene.6364451","volume":"9","author":"M Chang","year":"2007","unstructured":"Chang M, et al. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes & Immunity. 2007;9(2):176\u201381.","journal-title":"Genes & Immunity."},{"issue":"1","key":"1635_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang M, et al. Gain-of-function mutation of card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A. Immunity. 2018;49(1):66\u201379 e5.","journal-title":"Immunity."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01635-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:22:59Z","timestamp":1706692979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01635-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01635-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental studies were approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai and performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was provided by the patient for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to Participate"}},{"value":"Informed consent was provided by the patient for publication of this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"DB is the founder and part owner of Lab11 Therapeutics. ABG has received honoraria as an advisory board member and consultant for Amgen, AnaptypsBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Dice Therapeutics, Eli Lilly, Janssen, Novartis, Sanofi, UCB, and Xbiotech and has received research\/educational grants from AnaptypsBio, Moonlake Immunotherapeutics AG, Novartis, Bristol-Myers Squibb, and UCB Pharma (all paid to Mount Sinai School of Medicine). SK has received consulting honoraria and research grants from Eli Lilly, Sanofi Regeneron, Incyte, UCB, Abbvie, Takeda, Janssen Pharmaceuticals, Pfizer, Arcutis, and Bristol-Myers Squibb.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"36"}}